June 9, 2026 - 22:58

Broadcom Inc. (AVGO) is gaining attention as a top contender for investors looking at the NASDAQ for a three-year hold. The semiconductor and infrastructure software giant recently received a price target upgrade from Benchmark, signaling continued confidence in the company's trajectory. On June 4, the firm raised its price target on Broadcom shares to $545 from $485, while keeping a Buy rating on the stock.
The analyst behind the move noted that recent share weakness created a buying opportunity. Broadcom has been a key player in the custom chip space, particularly with its AI-related networking and accelerators. The company's diversified revenue streams, which include enterprise software and data center components, provide a buffer against cyclical downturns in the broader chip market.
For long-term investors, the three-year outlook appears solid. Broadcom's acquisition strategy has been disciplined, and its integration of VMware is expected to unlock recurring revenue. While the stock is not immune to market volatility, its strong free cash flow and dividend growth make it a candidate for patient portfolios. The current price target suggests roughly a 12% upside from recent levels, but analysts see more room to run as AI demand accelerates. For those seeking stability on the NASDAQ, Broadcom remains a name to watch.
June 9, 2026 - 03:28
Australian Consumers Are Deeply Pessimistic as Finances SqueezedAustralian consumer sentiment has fallen into what analysts describe as deeply pessimistic territory, driven by relentless cost of living pressures and growing unease over the housing market. The...
June 8, 2026 - 23:51
Ballard Spahr’s Consumer Financial Services Group Earns National Recognition Again from Chambers USA in 2026Ballard Spahr`s Consumer Financial Services Group has secured a spot in the 2026 edition of Chambers USA: America`s Leading Lawyers for Business. This marks another year of national recognition for...
June 8, 2026 - 10:49
Enact Holdings Continues To Be The Driver For Genworth FinancialGenworth Financial continues to lean heavily on its majority stake in Enact Holdings, a mortgage insurance provider that now stands as the company`s most valuable asset. With Enact currently valued...
June 7, 2026 - 23:29
Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish OnAclaris Therapeutics Inc. (NASDAQ:ACRS) is drawing renewed attention from Wall Street as a penny stock worth watching. On May 8, analysts at Stifel reiterated a Hold rating on the stock but raised...